Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeynep Eroglu

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Medical Oncology|January 12, 2016
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapyZeynep Eroglu, Antoni Ribas
Expert Opinion on Orphan Drugs|December 22, 2018
Updates and challenges on treatment with BRAF/MEK-inhibitors in melanomaZeynep Eroglu, Alpaslan Ozgun
Current Oncology Reports|March 22, 2020
Treatment Options for Advanced Melanoma After Anti-PD-1 TherapyNalan Akgul Babacan, Zeynep Eroglu
Cancer Chemotherapy and Pharmacology|May 3, 2013
A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladderZeynep Eroglu, John P Fruehauf
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Analysis of circulating tumor cells in breast cancerZeynep Eroglu, Odicie Fielder, George Somlo
Therapeutic Advances in Medical Oncology|April 28, 2022
Combination targeted and immune therapy in the treatment of advanced melanoma: a valid treatment option for patients?Shahla Bari, Jameel Muzaffar, Zeynep Eroglu
American Journal of Clinical Dermatology|December 28, 2020
Mechanisms of Resistance to BRAF-Targeted Melanoma TherapiesOzgecan Dulgar, Tugce Kutuk, Zeynep Eroglu
The Oncologist|January 18, 2014
Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancerZeynep Eroglu, Tomoko Tagawa, George Somlo
Journal of Food Science|November 24, 2024
Changes in quality characteristics and inactivation of Salmonella in cake, including oleogel used as a fat replacer, baked with two different methodsNecla Ozdemir-Orhan, Zeynep Eroglu, Basri Omac
Oncotargets and Therapy|December 28, 2018
Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapyJames Sun, Jonathan S Zager, Zeynep Eroglu
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|January 12, 2016
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapyZeynep Eroglu, Antoni Ribas
Expert Opinion on Orphan Drugs|December 22, 2018
Updates and challenges on treatment with BRAF/MEK-inhibitors in melanomaZeynep Eroglu, Alpaslan Ozgun
Current Oncology Reports|March 22, 2020
Treatment Options for Advanced Melanoma After Anti-PD-1 TherapyNalan Akgul Babacan, Zeynep Eroglu
Cancer Chemotherapy and Pharmacology|May 3, 2013
A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladderZeynep Eroglu, John P Fruehauf
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Analysis of circulating tumor cells in breast cancerZeynep Eroglu, Odicie Fielder, George Somlo
Therapeutic Advances in Medical Oncology|April 28, 2022
Combination targeted and immune therapy in the treatment of advanced melanoma: a valid treatment option for patients?Shahla Bari, Jameel Muzaffar, Zeynep Eroglu
American Journal of Clinical Dermatology|December 28, 2020
Mechanisms of Resistance to BRAF-Targeted Melanoma TherapiesOzgecan Dulgar, Tugce Kutuk, Zeynep Eroglu
The Oncologist|January 18, 2014
Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancerZeynep Eroglu, Tomoko Tagawa, George Somlo
Journal of Food Science|November 24, 2024
Changes in quality characteristics and inactivation of Salmonella in cake, including oleogel used as a fat replacer, baked with two different methodsNecla Ozdemir-Orhan, Zeynep Eroglu, Basri Omac
Oncotargets and Therapy|December 28, 2018
Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapyJames Sun, Jonathan S Zager, Zeynep Eroglu
Pageof 12